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Thioredoxin reductaseHigh-fat diet (HFD) can induce oxidative stress. Thioredoxin (Trx) and thioredoxin reductase (TrxR)
are critical antioxidant proteins but how they are affected by HFD remains unclear. Using HFD-
induced insulin-resistant mouse model, we show here that liver Trx and TrxR are signiﬁcantly
decreased, but, remarkably, the degree of their S-acylation is increased after consuming HFD. These
HFD-induced changes in Trx/TrxR may reﬂect abnormalities of lipid metabolism and insulin signal-
ing transduction. HFD-driven accumulation of 4-hydroxynonenal is another potential mechanism
behind inactivation and decreased expression of Trx/TrxR. Thus, we propose HFD-induced impair-
ment of liver Trx/TrxR as major contributor to oxidative stress and as a novel feature of insulin
resistance.
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Oxidative stress results from an imbalance between the gener-
ation of reactive oxygen species (ROS) and cellular antioxidant
capacities. After consuming high-fat diet (HFD), ROS production
in rat liver was increased dramatically [1], which preceded the
onset of insulin resistance [2], the key etiological defect that
deﬁnes type 2 diabetes. There are a number of reported causes
for HFD to induce oxidative stress. However, it remains unknown
how thioredoxin (Trx) system, a critical antioxidant system,
changes under HFD feeding conditions.
Trx system, consisting of Trx, thioredoxin reductase (TrxR) and
NADP(H), is present in all living cells. TrxR catalyzes the reduction
of Trx by NADPH. Mammalian TrxR is a selenoprotein with ROS
scavenging ability [3]. The reduced form of Trx has diverse biolog-
ical functions. For example, it acts as an electron donor for glutathi-
one peroxidase [4] and Trx peroxidase [5] to remove H2O2 and
organic peroxides; or serves as a direct inhibitor of apoptosissignal-regulating kinase-1 (ASK-1) against apoptosis [6]. The initial
landmark observation in the relationship between Trx and redox
state of insulin was made by Arne Holmgren [7], who showed
the reduction of insulin disulﬁde by reduced Trx. Later studies
demonstrated that Trx system could denitrosylate and trans-S-nit-
rosylate target proteins [8], which again links this system to insu-
lin-related events because S-nitrosylation may inﬂuence insulin
signaling pathway via regulating the activity of protein-tyrosine
phophatase-1B (PTP-1B), a negative regulator of insulin signal
transduction [9], or other insulin-signaling proteins [10]. However,
it is somewhat puzzling that TrxR was reported to participate in
the counter-regulation of insulin signaling by increasing liver
PTP-1B activity [11]; in type 2 diabetes patients, the level of serum
Trx was signiﬁcantly higher than that in healthy controls [12];
whereas oxidants are overabundant in mammalian skeletal muscle
under insulin-resistant conditions [13], similar etiologic events
also occur in the liver [14]. Given that extracellular compartments
are maintained at much more oxidizing potentials than cellular
redox environment, the redox status of intracellular Trx system
differs dramatically from that of extracellular (including serum)
one, and this system is involved in different events depending on
location, we therefore speculated that the change of Trx/TrxR in
organs might be different from that in serum under insulin-resis-
tant conditions. As liver has a supreme role in the onset of insulin
resistance syndrome [15], in this study we examined how liver Trx
and TrxR change in HFD-induced insulin-resistant mice.
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2.1. Animals and diets
All animal experiments were approved by the Animal Care and
Use Committee of Beijing, China. 4-week-old male C57BL/6J mice
were obtained from Animal Center of the Institute of Laboratory
Animal Sciences, Chinese Academy of Medical Sciences & Peking
Union Medical College. The animals were housed under conditions
of controlled temperature (21–23 C), humidity (40–60%), 12 h
lighting (06:00–18:00)/dark (18:00–06:00) cycle. They were
allowed ad libitum access to water and fed either with standard
laboratory chows (composed of 12% fat, 62% carbohydrate and
26% protein based on caloric content for control group) or high-
fat diets (composed of 50% fat, 36% carbohydrate and 14% protein
based on caloric content for HFD group) for 13 weeks.
2.2. Characterization of insulin resistance
For oral glucose tolerance test (OGTT) and insulin tolerance test
(ITT), the mice were fasted for 2 h before oral administration of
glucose (2 g/kg) or before subcutaneous injection of insulin
(0.26 U/kg). Blood samples were collected from the tail vein at 0,
30, 60 and 120 min, respectively, after glucose load or insulin load,
and used to determine glucose concentrations. Area under the glu-
cose concentration versus time curve (AUC) was calculated.
For hyperinsulinemic-euglycemic clamp test, the mice were
fasted for 4–5 h, and then anesthetized with sodium pentobarbital
(80 mg/kg i.p.) and given heparin (1 U/kg i.v.). The left internal jug-
ular vein was catheterized for infusing insulin or glucose. The right
internal jugular artery was catheterized for blood sampling. Blood
(10 ll) was collected at 10 min interval to immediately measure
plasma glucose concentrations. Afterwards, mice received a
prime-continuous infusion of human insulin (Lilly, USA) at a rate
60 pmol/kg min using a Programmable Syringe Pump (Cole Parm-
er, USA). Blood glucose was clamped at the basal level
(95 ± 5 mg/dl) with a variable rate infusion of 10% glucose using
a Low-ﬂow High-accuracy Pump (IPC, ISMATEC, Switzerland), to
keep blood glucose levels stable. After at least 20 min, blood sam-
ples were taken to measure glucose infusion rate (GIR). The exper-
iments were repeated three times and data were averaged.
Hepatic insulin-dependent glucose uptake was evaluated by
injecting 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-
deoxyglucose (2-NBDG, a ﬂuorescent indicator for measuring glu-
cose uptake) (250 lg/mice). After 60 min, the mice were killed by
exsanguinations, and liver was immediately collected for preparing
homogenate. Protein content and 2-NBDG ﬂuorescence in liver
homogenate were determined. Uptake of 2-NBDG was expressed
as mg 2-NBDG/g protein.
Modiﬁed Folch’s method was used to extract total lipids from
the livers. The level of triglyceride (TG) was determined using TG
Assay Kit (BioSino Bio-technology and Science Inc., China).
2.3. Blood sample collection and protein extraction from mouse liver
Blood samples were collected from the orbital sinus of the mice
that were food deprived overnight, followed by centrifugation at
3500 rpm/min for 10 min to obtain supernatants. After mice were
sacriﬁced, livers were collected and snap frozen in liquid nitrogen,
and then stored at 80 C until used.
The frozen livers were pulverized, and then suspended in
appropriate volumes of lysis buffer [containing 8 M urea, 2 M thio-
urea, 0.5% (w:v) CHAPS, 2% (w:v) ampholyte, 1% DTT, 1 mM PMSF,
50 lg/ml DNaseI, 50 lg/ml Rnase]. Sonication was operated on ice
using an ultrasonic probe, which was set for 20 cycles: 15ssonication ‘‘ON’’ and 30 s sonication ‘‘OFF’’, followed by centrifuga-
tion for 30 min at 14,000 rpm/min, 4 C. The resulting supernatant
was used as liver protein extracts. Protein concentration was
determined using a Bradford protein assay kit.
2.4. Assay of liver Trx/TrxR
Trx/TrxR activity was determined using the modiﬁed method of
super-insulin assay [16]. An assay mixture contained 0.25 M phos-
phate buffer, pH 7.5, 10 mM EDTA, 2 mM NADPH, 1.07 mM bovine
insulin, and 40 ll TrxR (for measuring Trx) or Trx (for measuring
TrxR). The working solution of Trx or TrxR had been standardized
through diluting its stock solution with 50 mM potassium phos-
phate buffer, pH 7.5 containing 1 mM EDTA (PE buffer), to give a
ﬁnal TrxR activity of D150 mA 412 nm/min or a ﬁnal Trx activity
of D10 mA 340 nm/min in 100 ll reaction volume. The reaction
was started by mixing 20 ll of liver extract with 40 ll assay mix-
ture, and incubated at room temperature for 30 min. The reaction
was terminated by adding 150 ll of 0.1 mM DTNB-8 M GuaHCl
in 0.2 M phosphate buffer, pH 7.5. Trx/TrxR activity was measured
by following an increase in absorbance at 412 nm due to Trx/TrxR-
dependent reduction of DTNB to TNB, and expressed as
DA412 nm/mg proteinmin. A value of control reaction, in which
the liver extract was not added until the termination of the reac-
tion, was determined to correct for non Trx/TrxR-dependent reduc-
tion of DTNB. Protein levels of Trx/TrxR were determined by
Western blotting.
Total tissue RNA was extracted from the livers of mice using Tri-
zol reagent (Invitrogen, USA). The mRNA (1 lg) was ﬁrst reverse-
transcribed into cDNA with cDNA reverse transcriptase (Promega,
USA). RealTime (RT)-PCR was performed using 2 ll of ten-times
diluted cDNA in a 25 ll reaction volume with an ABI GeneAmp
5700 Sequence Detection System and QuantiTect SYBR Green
PCR Master Mix (Toyobo, Japan). The sequence of the primers
were: Trx1 forward, 50-CGT GGT GGA CTT CTC TGC TAC GTG
GTG-30; Trx1 reverse, 50-GGT CGG CAT GCA TTT GAC TTC ACA
GTC-30; TrxR1 forward, 50-GGC CAA CAA AAT CGG TGA ACA CAT
GGA AG-30; TrxR1 reverse, 50-CGC CAG CAA CAC TGT GTT AAA
TTC GCC CT-30; b-action forward, 50-AGC CAT GTA CGT AGC CAT
CC-30; b-action reverse, 50-CTC TCA GCT GTG GTG GTG AA-30. The
mRNA levels of Trx1 and TrxR1 were normalized to the internal
control b-actin as a housekeeping gene. Thermal cycle conditions
were as follows: incubation at 95 C for 5 min followed by 40
cycles of denaturation at 95 C for 15 s, annealing at 60 C for
15 s and extension at 72 C for 45 s. Relative expression of Trx1
and TrxR1 genes was analyzed through comparison to the refer-
ence gene (b-actin) expression using ABI GeneAmp 5700 SDS
software.
2.5. Analysis of liver Trx1/TrxR1 S-acylation
Acyl-Biotin Exchange assay [17] was used with slight modiﬁca-
tion. Brieﬂy, mouse livers were homogenated in lysis buffer con-
taining 100 mM Tris–HCl, 2 mM EDTA, 2.5% SDS, 0.5% Triton and
1 mM PMSF, followed by ultrasonication and centrifugation to
obtain supernatant and determine the content of total proteins.
Then, the supernatant was mixed with 50 mM iodoacetamide
(IAM), and stayed at 37 C for 5 h in the dark, followed by dialysis
against 100 mM Tris–HCl, 2 mM EDTA, pH 7.5 to remove the excess
IAM. The resulting sample was mixed with 50 mM NH2OH and
incubated at 37 C for another 5 h, then divided into two equal
parts. One part was mixed with 40 ll of reaction buffer containing
50 mM Tris–HCl, 5 mM EDTA, pH 8.3, which was used as control.
The other part (test sample) was mixed with 40 ll of 25 mg/ml
EZ-Link iodoacetyl-PEG2-Biotin (Pierce Biotechnology, Rockford,
930 H. Qin et al. / FEBS Open Bio 4 (2014) 928–935IL, USA). The both were incubated at 37 C for 5 h. After removing
the excess EZ-Link iodoacetyl-PEG2-Biotin by dialysis, streptavidin
agarose beads (Invitrogen, Dynal AS, Oslo, Norway) was added
either into the control or test samples, respectively, followed by
incubation at 4 C for 12 h. The beads were collected via centrifuga-
tion, washed for 5 times, and re-suspended by 1  SDS sample
buffer, which were boiled for 10 min. The eluted proteins were
subjected to SDS–PAGE and Western blotting analysis.
2.6. Western blotting
For determining protein levels of Trx/TrxR, the liver extract
(120 lg of total protein per lane) was separated on a 12% SDS–
PAGE. For detecting 4-HNE-protein adducts, the liver extract
(60 lg of total protein per lane) was separated on a 10% SDS–PAGE
gel. The resolved proteins were then electroblotted onto polyvi-
nyldiﬂuoride membranes (Novex, America). The target proteins
were detected by using monoclonal antibody of TrxR1 (1:1000
dilution), Trx1 (1:1000 dilution), GADPH (1:10,000 dilution) or
polyclonal antibody of 4-HNE (1:5000 dilution) (Calbiochem,
USA), respectively. The bound antibodies were detected by horse-
radish peroxidase-labeled secondary antibody (1:1000 dilution).
Protein bands were visualized using an enhanced chemilumines-
cence detection system (ECL) according to the instruction given
by the manufacturer. The experiments were performed in
triplicate.
2.7. Two-dimensional gel electrophoresis (2-DE) of liver extracts
2-DE analysis was made on three mice in each group. Isoelectric
focusing (IEF) was conducted on pH 3–10 or pH 5–8 17-cm immo-
bilized pH gradient (IPG) strips, respectively, in Multiphor II elec-
trophoresis apparatus (Amersham, America). First, precast IPG
strips (Bio-Rad, America) were removed from refrigerator and
rehydrated with swelling buffer (8 M urea, 2 M thiourea, 0.5%
CHAPS, 0.52% ampholyte, 0.02% bromophenol blue, 1% DTT) for
12 h. The total protein (1 mg) was loaded on each analytical gel.
The electric focusing was carried out at 20 C in ﬁve steps: (1) 0–
500 V gradient for 500 Volt h (Vh); (2) a constant potential of
500 V for 2500 Vh; (3) 500–3500 V gradient for 10,000 Vh; (4) aFig. 1. Insulin resistance occurred in the mice fed on HFD for 13 weeks. (A and B) OGT
metabolize glucose (Fig. 1A, upper curve) compared with control group (Fig. 1A, lower cu
less sensitive to insulin (Fig. 1C, upper curve) than controls (Fig. 1C, lower curve) (n = 8).
insulin-dependent glucose uptake, analyzed by hyperinsulinemic euglycemic-clamp (n =constant potential of 3500 V for 50,000 Vh and (5) 3500–500 V gra-
dient for 8000 Vh. Afterwards, the strips were equilibrated in buf-
fer I (50 mM Tris–HCl, pH 6.8, 6 M urea, 30% glycerol, 2% SDS, 2%
DTT and 0.02% bromophenol blue) for 15 min, followed by treat-
ment with equilibration buffer II (50 mM Tris–HCl, pH 6.8, 6 M
urea, 30% glycerol, 2% SDS, 2.5% IAA and 0.02% bromophenol blue)
for 15 min. The IPG strips were then electrophoresed on 12% SDS–
polyacrylamide gel at 250 V for about 5 h in a Protean II XL system
(Bio-Rad, America) using Tris–glycine buffer.
2.8. Gel staining, image acquisition and mass spectrometry analysis
The 2-DE gels were stained with Coomassie Brilliant Blue (10%
ammonium sulfate, 10% phosphoric acid, 0.12% G250 and 20%
methanol). The stained gels were then scanned at 300 dpi with a
PowerLook 2100XL scanner system (UMAX, America) to obtain
images, which were then analyzed using PDQuest7.3.0 software
(Bio-Rad). All protein spots with statistically signiﬁcant difference
(=1.4-fold) in intensity between control and HFD groups were
excised.
The excised spots were cut into 1 mm3 pieces, which were
washed three times with water, then destained in 50% (v/v) aceto-
nitrile (ACN) (Fisher, America)/100 ll of 25 mM pH 8.0 ammonium
bicarbonate (Fluka, America) for 15 min, repeating 3 times. The gel
pieces were dehydrated in 30 ll of 100% ACN for 5 min, and then
digested with 8 ll of 0.1 mg/ml trypsin in 25 mM NH4HCO3 (Pro-
mega, America) at 37 C overnight. An aliquot of the digestion solu-
tion was mixed with an aliquot of a-cyano-4-hydroxycinnamic
acid (Fluka, America). This mixture was deposited onto an Anchor
Chip MALDI probe, allowed to dry at room temperature, and was
identiﬁed by LC–MS–MS using 4700 Proteomics Analyzer (ABI)
with 4000 Series software. The instrument was operated with a
laser intensity 3200, which can detect molecular mass spectra
700–4000 Da. Protein identiﬁcation was performed by searching
against NCB-Inr, SWISS-PROT and IPI database using GPS
Explorer™ v3.5 software. The search parameters were as follows:
precursor fragment mass tolerance of ±0.1 Da; the number of
missed cleavage allowed was 1; carbamidomethylation of Cys res-
idues as ﬁxed modiﬁcations; oxidized amino acids as variable
modiﬁcations.T in HFD and control groups. The mice in HFD group operated at lower ability to
rve) (n = 8). (C and D) ITT in HFD and control groups. (C) The mice in HFD group were
(E) Whole body glucose utilization (clamp glucose infusion rate, GIR) and (F) hepatic
6). Values are mean ± SD. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
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To determine expression levels of serum leptin, liver leptin
receptor, PTP-1B and PPARa/c, ELISA was performed using the pro-
tein-speciﬁc monoclonal antibody. Proteins in the samples were
diluted to reach the concentration within the range of standard
curve. Other procedures followed instructions for ELISA kit (ADL,
America).
2.10. Statistical analysis
T-test was used to compare the mean values between two
groups. Statistical analyses were performed using Excel. A P-value
less than 0.05 was considered statistically signiﬁcant.
3. Results and discussion
3.1. Characteristics of HFD-induced insulin resistance
To build the mouse model of insulin resistance, mice were
divided into HFD and control groups, receiving a HFD or a standard
diet, respectively. After 13 weeks of HFD feeding, glucose tolerance
was signiﬁcantly impaired. At 15, 60 or 120 min after glucose load,
blood glucose levels in HFD group were 44%, 83%, or 90% higher
than those in control group, respectively (Fig. 1A); AUC value in
HFD group was about 1.6-fold higher than that in control group
(Fig. 1B). Meanwhile, the sensitivity to insulin was decreased as
well after consuming HFD. At 30 min after insulin administration,
blood glucose levels were decreased by 45% in control group and
by 8% in HFD group, as compared to those before insulin injections
(Fig. 1C); AUC value in HFD group was about 1.5-fold higher than
that in control group (Fig. 1D). In addition, glucose-infusion rate
(GIR) was decreased by 7.8-fold in HFD group (Fig. 1E), and the
hepatic insulin-dependent glucose uptake was decreased by 1.8-
fold in HFD group (Fig. 1F), as compared with those in control
group. These results conﬁrm the occurrence of HFD-induced
hepatic and systemic insulin resistance.
3.2. Effect of HFD on liver Trx/TrxR activity and expression
Using this mouse model, we examined the changes in liver Trx/
TrxR. The activity of total Trx or TrxR in HFD group was reduced by
70% or 56%, respectively, relative to control group (Fig. 2A, n = 8).Fig. 2. HFD-induced decrease in liver Trx/TrxR. (A) Speciﬁc activity of total TrxR and Trx
and Trx1, detected by Western blotting with anti-TrxR1 or anti-Trx1 monoclonal antib
TrxR1 and Trx1 immunoblots. (C) mRNA levels of TrxR1 and Trx1, determined by quantTo test if the expression levels of Trx/TrxR also go down, three sam-
ples from each group were chosen at random for Western blot
analysis. As shown in upper panel of Fig. 2B, the protein levels of
cytosolic Trx and TrxR (referred to as Trx1/TrxR1) were generally
lower in HFD group than those in control group. The decrease in
the average amount of Trx1 or TrxR1 protein in HFD group was
about 70% or 38% relative to control group (n = 3) (lower panel of
Fig. 2B). Consistent with these changes, HFD group showed signif-
icantly lower mRNA level of Trx1 (51% reduction) or TrxR1 (37%
reduction) as compared with control (Fig. 2C, n = 6). These results
suggest that reduction of hepatic Trx/TrxR is a previously unrecog-
nized aspect of insulin resistance. HFD-induced decrease in Trx1/
TrxR1 expression seems to be a major contributor to reduction of
total Trx/TrxR activity. However, activity reduction of TrxR was
more profound than protein reduction, suggesting that dysfunction
of TrxR by posttranslational modiﬁcation(s) cannot be excluded.
3.3. Effect of HFD on liver Trx1/TrxR1 S-acylation
One of TrxR1 variants has been reported to be modiﬁed by
fatty acid at its N-terminal MGC motif [18]. Protein S-acylation
is a common post-translational modiﬁcation of proteins [19]. To
address a potential relationship between lipid accumulation and
Trx1/TrxR1 S-acylation, we further analyzed this mouse model.
In HFD group, liver TG content was 1.9-fold higher relative to
control (Fig. 3A). We next examined Trx1/TrxR1 S-acylation using
a modiﬁed Acyl-Biotin Exchange assay, the method is commonly
used to quantitatively assess protein palmitoylation [17]. Free
thiol groups in the liver extracts were ﬁrst blocked by IAM, and
then treated with NH2OH to selectively cleave thioester bonds
and generate nascent thiols. The latter were labeled by thiol-reac-
tive biotinylation reagent (EZ-Link iodoacety1-PEG2-Biotin). The
biotin labeled proteins were then captured via streptavidin aga-
rose, from which the bound proteins were eluted, and subjected
to Western blot analysis using monoclonal anti-Trx1 or anti-
TrxR1 primary antibody. This result revealed that the biotin-
labeled-proteins included Trx1 and TrxR1. To further control for
possible false-positive identiﬁcation, the eluates from streptavidin
agarose incubated with the liver extracts that had not been trea-
ted with EZ-Link iodoacety1-PEG2-Biotin were analyzed in paral-
lel by Western blotting in each experiment. Trx1 and TrxR1 were
not detected in the absence of EZ-Link iodoacety1-PEG2-Biotin.
These ﬁndings are consistent with the presence of S-acylation, determined by super-insulin assay (n = 8). (B) Upper panel: protein levels of TrxR1
ody. GADPH as an internal reference (n = 3). Lower panel: density quantiﬁcation of
itative RT-PCR (n = 6). All values are means ± SD. ⁄P < 0.05.
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S-acylation appeared to be enhanced in HFD group (upper panel
of Fig. 3B). The average extent of Trx1 S-acylation or TrxR1 S-acyl-
ation was about 1.5-fold or 1.7-fold higher in HFD group than in
control group, respectively (lower panel of Fig. 3B). This suggests
that S-acylation may mediate the negative effect of HFD on Trx1/
TrxR1. The detailed mechanism for Trx1/TrxR1 inhibition by S/Se-
acylation is under investigation. As all isoforms of mammalian
Trx/TrxR contain the conserved active-site Cys/Sec residues, S/
Se-acylation of mitochondrial Trx/TrxR is also possible. Given that
modiﬁcation of Trx-Cys residue(s) may stimulate ASK1-mediated
apoptosis [20], the enhanced S-acylation of Trx1 is most likely
another potential mechanism behind lipid accumulation-induced
apoptosis in liver cells [21].Fig. 3. TG content and Trx/TrxR S-acylation. (A) TG levels in mice livers (n = 6). (B) Upper
HFD group using Acyl-Biotin Exchange assay protocol, followed by Western blotting with
Methods. Lanes 1 and 3, no acylated TrxR1/hTrx1 bound to streptavidin-agarose. Lanes
proteins. Lower panel: density quantiﬁcation of TrxR1/hTrx1 immunoblots. Data represe
Fig. 4. Altered proteins detected by ELISA. (A) PPARc and (B) PPARa levels in the nuclear
level and (E) PTP-1B level in the liver protein extracts. Data represent mean ± SD from e3.4. HFD-induced decrease in liver Trx/TrxR as a marker of abnormal
lipid metabolism
A variety of proteins have been described to participate in lipid
metabolism. For instance, activation of peroxisome proliferator-
activated receptor (PPAR)c can increase uptake of fatty acid in
brown fat, but decrease uptake and utilization of fatty acid in liver
[22]; PPARa activation favors fatty acid oxidation in liver [23]; lep-
tin negatively regulates PPARc gene expression [24]; inhibition of
protein tyrosine phosphatase-1B (PTP-1B) reduces TG accumula-
tion in addition to improving insulin sensitivity [25]. Using ELISA,
we observed that HFD group had a signiﬁcant decrease in hepatic
PPARc (Fig. 4A) and a decreased trend of hepatic PPARa (Fig. 4B),
while showed a signiﬁcant increase in PTP-1B (Fig. 4C), serumpanel: S-acylated TrxR1/hTrx1 were separated from liver extracts of either control or
anti-TrxR1/hTrx1 monoclonal antibodies. Methods are detailed under Materials and
2 and 4, S-acylated TrxR1/hTrx1 detected in streptavidin-enriched biotin-labeled
nt mean ± SD from three mice per group. ⁄P < 0.05, and ⁄⁄⁄P < 0.001.
protein extracts from frozen mice livers. (C) Serum leptin levels. (D) Leptin receptor
ight mice per group. All experiments were done in triplicate. ⁄P < 0.05.
Fig. 5. Representative examples of the liver proteins separated on 2-DE gels. The liver extracts either from control group or from HFD group (n = 3) were separated by 2-DE,
respectively. The indicated protein spots have been identiﬁed by mass spectrometry. The images were analyzed using PDQuest7.3.0 software.
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(Fig. 4E). It is likely that TG accumulation, due to HFD-induced dys-
function of lipid metabolism including down-regulated PPARc/a in
parallel with up-regulated PTP-1B and leptin/leptin receptor, leads
to increased level of saturated fatty acid (FA) that in turn promotes
modiﬁcation of Trx/TrxR by S-acylation, as observed in HFD group
(Figs. 3 and 7).Table 1
HFD-induced alterations in mouse liver proteins.
Protein accession number E.C. number Protein identity
gi|84871986 EC1.11.1.9 Glutathione peroxidase-1
sp|P19157 EC2.5.1.18 Glutathione S-transferase P 1
IPI00323911 EC2.5.1.18 Glutathione S-transferase A4
sp|O09131 EC2.5.1.18 Glutathione S-transferase x 1
sp|P17751 EC5.3.1.1 Triosephosphate isomerase
gi|22128627 EC1.1.1.14 Sorbitol dehydrogenase
sp|Q8K157 EC5.1.3.3 Aldose 1-epimerase
gi|21450129 EC2.3.1.9 Acetyl-CoA acetyltransferase 2
IPI:IPI00894663 EC6.3.4.16 Carbamoyl-phosphate synthetase 1
gi|25453414 EC6.3.4.5 Argininosuccinate synthase
sp|Q91YI0 EC4.3.2.1 Arginosuccinase
sp|Q61176 EC3.5.3.1 Arginase-1
sp|Q29555 EC2.1.1.20 Glycine N-methyltransferase
IPI00230440 EC3.3.1.1 Adenosylhomocysteinase
sp|P97532 EC2.8.1.2 3-Mercaptopyruvate sulfurtransfera
sp|O09173 EC1.13.11.5 Homogentisate 1,2-dioxygenase
sp|P0C2X9 EC1.5.1.12 Delta-1-pyrroline-5-carboxylate de
sp|Q8BH00 EC1.2.1. Retinal dehydrogenase 4
IPI00857439 –c ATP synthase a-subunit
sp|Q8BFR5 – Elongation factor Tu
sp|O42265 EC3.4.25.1 Proteasome a-type subunit
sp|P13645 – Cytokeratin-10
Patterns of liver proteins from HFD and control groups were examined by comparative
a ‘‘HFD vs. Control’’ means protein changes in HFD group compared with control.
b ‘‘’’ means a decrease of spot intensity and ‘‘+’’ means an increase of spot intensity.
c Means without E.C. number.3.5. HFD-induced decrease in liver Trx/TrxR as an indicator of
abnormal insulin signaling
In the liver, insulin actions include activation of insulin receptor
substrate (IRS)-1-dependent phosphoinositide 3-kinase (PI 3-
kinase), protein kinase B/Akt [26] and forkhead box O1 (Foxo1),
in which a major role of hepatic Akt is to restrain the activity ofAssociated function HFD vs. Controla
Fold change P-value
Anti-oxidation 3.3b <0.01
+1.6 <0.05
2.4 <0.05
1.8 <0.05
Glucose metabolism 1.4 <0.05
1.8 <0.05
+1.4 <0.05
Cholesterol synthesis +2.8 <0.05
Urea cycle Present only in control
2.7 <0.05
3.2 <0.01
1.8 <0.05
Amino acid metabolism 3.0 <0.01
Present only in HFD
se +1.6 <0.05
+1.7 <0.05
hydrogenase 2.0 <0.05
Vitamin A metabolism 1.8 <0.05
Mitochondria ATP production 1.8 <0.05
Mitochondria translation +1.4 <0.05
Protein degradation +1.6 <0.05
Cytoskeleton +1.4 <0.05
proteomic analysis.
Fig. 6. 4-HNE-mediated effect of HFD on Trx/TrxR. (A) Upper panel: a representative
of 4-HNE levels in liver extracts from control and HFD groups examined by Western
blot. Lower panel: average levels of 4-HNE detected by Western blot assays,
representing mean ± SD from three mice per group. (B) Upper panel: a represen-
tative of TrxR1 and Trx1 expression in the presence or absence of 50 lM 4-HNE.
Lower panel: average levels of TrxR1/Trx1 detected by Western blot assays. Values
are means ± SD (n = 3). ⁄P < 0.05; ⁄⁄P < 0.01.
934 H. Qin et al. / FEBS Open Bio 4 (2014) 928–935Foxo1 [27]. Decrease in Trx/TrxR is associated with insulin resis-
tance, suggesting potential role of insulin signaling in mediating
this process. To examine the possible involvement of Akt and
related proteins, we examined HFD-induced liver proteomic
changes. Protein extracts either from HFD group or from control
group were separated by 2-DE, respectively. Protein spots were
visualized by staining with Coomassie Brilliant Blue. Using wide-
range (pI 3–10) 2-DE gels for the protein separation, two proteins
were found to be signiﬁcantly elevated in HFD group than those in
control, but proteins were not well separated (lower pane of Fig. 5).
High resolution for the protein separation was attained in pH rangeFig. 7. Molecular mechanism of HFD-induced decrease in liver Trx/TrxR. HFD results in
increased accumulation of 4-HNE. The use of proteomic analysis and ELISA has allowed
mediate the effect of HFD on Trx/TrxR.5–8 (upper panel of Fig. 5). The protein spots distributed between
pH 5–8 were approximately 1000. Thirty-four protein spots were
differentially expressed by more than 1.4-fold in HFD group versus
control group, which were excised from the 2-DE gels and identi-
ﬁed by MALDI-TOF-MS analysis. Twenty-two spots were success-
fully identiﬁed. The identiﬁed proteins are grouped according to
their functions and shown in Table 1.
Among them, expression of cytokeratin-10 (CK-10), also known
as keratin-10 (K10), was signiﬁcantly up-regulated in liver from
HFD group. CK-10 has been reported to inhibit Akt [28]. Thus,
CK-10 and PTP-1B play synergistic effect on Akt. PTP-1B dephos-
phorylates insulin receptor [29] and insulin receptor substrate-1
(IRS-1) [30], which leads to decrease in PI 3-kinase-dependent acti-
vation of Akt [31,32]. The defect in Akt has been shown to correlate
with the activation of Foxo1 [27], the latter causes increased TG
accumulation and decreased fatty acid oxidation [33] (Fig. 7).
Consequently, saturated fatty acids (FA) were higher in HFD group
relative to control, and have considerable inﬂuence on Trx/TrxR by
S-acylation.
3.6. 4-HNE-mediated effect of HFD on liver Trx/TrxR
In addition, certain end products of lipid peroxidation, such as
4-hydroxynonenal (4-HNE), can inhibit Trx/TrxR activity [34]. We
showed that accumulation of 4-HNE adducts was driven by HFD
(Fig. 6A). To investigate the effect of 4-HNE on Trx/TrxR expression,
we treated hepatic cells with 50 lM 4-HNE. This treatment led to a
signiﬁcant decrease in Trx1 protein and a clear decreasing trend of
TrxR1 protein (Fig. 6B). As revealed by proteomic analysis, the mice
fed on HFD had a signiﬁcant decrease in glutathione S-transferase
(GST)-A4 and glutathione peroxidase 1 (GPx-1) (Table 1). GST-A4 is
central to 4-HNE detoxiﬁcation and metabolism [35]. GPx-1 enzy-
matically reduces hydrogen peroxide to water to limit its harmful
effects because hydrogen peroxide may induce lipid peroxidation
of cell membranes, generating 4-HNE [36]. Accordingly, the nega-
tive effect of HFD on Trx/TrxR through 4-HNE is best rationalized
in terms of forming 4-HNE-Trx/TrxR adducts or suppressing Trx/
TrxR synthesis. Meanwhile, decrease in Trx/TrxR sets up a vicious
cycle that augments oxidative stress (Fig. 7).decrease of liver Trx/TrxR, owing to increased degree of Trx/TrxR S-acylation and
the validation of involved proteins in lipid metabolism and insulin signaling, which
H. Qin et al. / FEBS Open Bio 4 (2014) 928–935 935In summary, the identiﬁcation of HFD-induced impairment in
liver Trx/TrxR provides a novel framework to understand the
molecular mechanism behind liver oxidative stress under insu-
lin-resistant conditions. As Trx and TrxR have a broad range of
substrates [37], sorting out the major roles of Trx/TrxR in the
pathogenesis of liver insulin resistance is crucial for designing
new strategies to cope with insulin resistance and relevant
diseases.
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